Home Tags Loxo Oncology
Tag: Loxo Oncology
Dispensed: Why Walgreens is partnering with Microsoft, inside the Loxo-Lilly deal, and controversial young blood startups
Welcome to Dispensed: a weekly dose of pharma, biotech, and healthcare news.
We’ll get you caught up on all the news you missed at the year’s biggest healthcare investor conference
Among the highlights: an $8 billion deal (and more to come?), a promising depression drug, and a strategy deep dive from a healthcare giant.
Pharma giant Eli Lilly just made an $8 billion bet on a cutting-edge scientific approach that uses DNA to treat cancer
Eli Lilly's $8 billion acquisition of the biotech company Loxo Oncology is a notably large deal, but it's open to additional ones, its CEO said.
The FDA just approved a drug that targets cancers based on DNA, rather than where the tumor is in your body
The FDA just approved a new cancer treatment in an unconventional way: not by tumor type, but rather by the genetic mutation the drug targets.
A drugmaker that’s taking an unconventional approach to cancer drugs just got a $1.5 billion endorsement
Loxo Oncology is building drugs that act on cancerous genetic mutations rather than the type of cancer a person has.